• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Pfizer offloads Capsugel to KKR for $2.4 billion

Pfizer offloads Capsugel to KKR for $2.4 billion

April 4, 2011 By MassDevice staff

Pfizer, Kohlberg Kravis Roberts

Pfizer Inc. (NYSE:PFE) is selling off its Capsugel unit to private equity firm Kohlberg Kravis Roberts & Co. L.P. (NYSE:KKR) in a $2.38 billion cash deal, the companies said today.

Peapack, N.J.-based Capsugel manufactures hard capsules and drug delivery systems for the pharmaceutical and nutrition industries and generated about $750 million in revenue last year, according to Pfizer. Its divestiture comes on the heals of the company’s $3.6 billion takeover of painkiller maker King Pharmaceuticals Inc. in November.

The world’s largest drug maker expects to fund stock repurchases with the proceeds from the divestiture in 2011 and also said it plans to “identify and invest in other opportunities to maximize its value, including business development.”

Pfizer had already announced plans to buy back $5 billion in shares this year. The company updated its 2011 revenue guidance range from $66.0 billion to $68.0 billion to $65.2 billion to $67.2 billion and pulled back its 2012 revenue targets from $63.0 billion $65.5 billion to $62.2 billion to $64.7 billion.

PFE shares were up about 0.6 percent in mid-day trading and are currently going for about $20.49 apiece.

News of the divestiture overshadowed a “Refusal to File” letter from the FDA for Pfizer’s new drug application for tafamidis, its experimental treatment for Transthyretin Familial Amyloid Polyneuropathy, an incurable neuro-degenerative disease. The FDA found that the application was not sufficiently complete to permit a substantive review, according to the company.

New York-based KKR’s investments in the health-care industry include publicly traded hospital chain HCA Holdings Inc. and orthopedic medical device manufacturer Biomet Inc.

Here’s a roundup of companies announcing mergers, acquisitions and divestitures.

    • Bruker completes of Michrom buyout
      Bruker Corp. (NSDQ:BRKR) announced the closing of its acquisition of Michrom Bioresources Inc., a 20 year old, privately owned company located in Auburn, Calif., after receiving unanimous Michrom shareholder approval. The acquisition is not expected to have a material effect on Bruker’s 2011 financials. All former Michrom employees have been offered employment by Bruker, and Michrom’s founder, Kerry Nugent, joined Bruker as senior vice president.
      Read more

 

    • DJO looks to raise $300 million to fund Dr. Comfort takeover
      DJO Global Inc. plans to offer, in a private offering subject to market and other conditions, $300 million aggregate principal amount of senior unsecured notes due 2018. Obligations under the notes will be guaranteed by all existing and future domestic subsidiaries that guarantee DJO Finance LLC’s (DJOFL) existing senior secured credit facilities, senior unsecured notes due 2014 and senior subordinated notes due 2017. DJOFL intends to use the net proceeds from the offering to fund the estimated $254.6 million purchase price for the acquisition of Rikco International, LLC, D/B/A Dr. Comfort , a provider of therapeutic footwear, pay estimated fees and expenses associated with the acquisition and the related financing and repay an estimated $25.4 million of borrowings currently outstanding on DJOFL’s senior secured revolving credit facility.
      Read more

 

    • OncoSec closes Inovio tumor therapy deal
      OncoSec Medical Inc. (OTC:ONCS) announced that on March 24 it completed its acquisition of certain assets of Inovio Pharmaceuticals, Inc. (NYSE Amex:INO) and entered into a license agreement with Inovio, pursuant to the terms of an asset purchase agreement with Inovio entered into on March 14.
      Read more

 

    • Techne buys Boston Biochem
      Techne Corp. (NSDQ:TECH) announced that as of April 1, its R&D Systems subsidiary has acquired the assets of Boston Biochem Inc., a developer and manufacturer of innovative ubiquitin-related research products.
      Read more

 

    • BAE closes Fairchild Imaging takeover
      BAE Systems Inc. completed the acquisition of the outstanding equity of privately owned Fairchild Imaging Inc. The proposed acquisition was announced January 21. Fairchild makes solid-state electronic imaging components, cameras, and systems for aerospace, industrial, medical, and scientific imaging applications.
      Read more

 

  • Quest completes Athena acquisition
    Quest Diagnostics Inc. (NYSE:DGX) closed its $740 million cash purchase of Athena Diagnostics Inc. from Thermo Fisher Scientific Inc. (NYSE:TMO). The Federal Trade Commission granted Quest an early termination of the premerger review for the deal last week.
    Read more

Filed Under: Mergers & Acquisitions, News Well, Pharmaceutical Tagged With: Capsugel, Kohlberg Kravis Roberts & Co, Pfizer

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy